BQ-123
N/A
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NameBQ-123
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[14]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMidwestern University
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of Wisconsin-MadisonPharmazz Inc
Inactive CompaniesUtah State UniversityThe Brigham and Women's HospitalEberhard-Karls Universitaet Tuebingen +[7]
Active Indications
Inactive Indications +[11]
Other Information
ATC CodeN/A
Related LinksWikipedia